Skip to main content
. Author manuscript; available in PMC: 2023 May 2.
Published in final edited form as: J Surg Oncol. 2014 Jun 24;110(4):375–382. doi: 10.1002/jso.23656

Fig. 2.

Fig. 2.

A: Locoregional progression-free survival. B:M0 versus M1. C: Well-/moderately differentiated versus poorly differentiated histology. D:External beam radiation therapy (EBRT) versus concurrent chemoradiation therapy (CCRT).